239 related articles for article (PubMed ID: 24168430)
1. Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts.
Kummu O; Turunen SP; Prus P; Lehtimäki J; Veneskoski M; Wang C; Hörkkö S
Immunology; 2014 Mar; 141(3):416-30. PubMed ID: 24168430
[TBL] [Abstract][Full Text] [Related]
2. Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation.
Kummu O; Turunen SP; Wang C; Lehtimäki J; Veneskoski M; Kastarinen H; Koivula MK; Risteli J; Kesäniemi YA; Hörkkö S
Antioxid Redox Signal; 2013 Oct; 19(10):1047-62. PubMed ID: 23311771
[TBL] [Abstract][Full Text] [Related]
3. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
[TBL] [Abstract][Full Text] [Related]
4. Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques.
Wang C; Turunen SP; Kummu O; Veneskoski M; Lehtimäki J; Nissinen AE; Hörkkö S
Int Immunol; 2013 Oct; 25(10):575-87. PubMed ID: 23900424
[TBL] [Abstract][Full Text] [Related]
5. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a.
Veneskoski M; Turunen SP; Kummu O; Nissinen A; Rannikko S; Levonen AL; Hörkkö S
Free Radic Biol Med; 2011 Aug; 51(4):834-43. PubMed ID: 21683785
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.
Hörkkö S; Bird DA; Miller E; Itabe H; Leitinger N; Subbanagounder G; Berliner JA; Friedman P; Dennis EA; Curtiss LK; Palinski W; Witztum JL
J Clin Invest; 1999 Jan; 103(1):117-28. PubMed ID: 9884341
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human monoclonal autoantibody Fab fragments against oxidized LDL.
Jeon YE; Seo CW; Yu ES; Lee CJ; Park SG; Jang YJ
Mol Immunol; 2007 Feb; 44(5):827-36. PubMed ID: 16793138
[TBL] [Abstract][Full Text] [Related]
8. Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.
Kyrklund M; Kummu O; Kankaanpää J; Akhi R; Nissinen A; Turunen SP; Pussinen P; Wang C; Hörkkö S
PLoS One; 2018; 13(1):e0191216. PubMed ID: 29329335
[TBL] [Abstract][Full Text] [Related]
9. IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope.
Que X; Widhopf GF; Amir S; Hartvigsen K; Hansen LF; Woelkers D; Tsimikas S; Binder CJ; Kipps TJ; Witztum JL
PLoS One; 2013; 8(6):e65203. PubMed ID: 23840319
[TBL] [Abstract][Full Text] [Related]
10. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
[TBL] [Abstract][Full Text] [Related]
11. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
[TBL] [Abstract][Full Text] [Related]
12. Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.
Gonen A; Hansen LF; Turner WW; Montano EN; Que X; Rafia A; Chou MY; Wiesner P; Tsiantoulas D; Corr M; VanNieuwenhze MS; Tsimikas S; Binder CJ; Witztum JL; Hartvigsen K
J Lipid Res; 2014 Oct; 55(10):2137-55. PubMed ID: 25143462
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune response to heat shock protein 60 of Aggregatibacter actinomycetemcomitans and cross-reactivity with malondialdehyde acetaldehyde-modified LDL.
Kyrklund M; Bildo M; Akhi R; Nissinen AE; Pussinen P; Hörkkö S; Wang C
PLoS One; 2020; 15(3):e0230682. PubMed ID: 32210456
[TBL] [Abstract][Full Text] [Related]
14. SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.
Choi SH; Gonen A; Diehl CJ; Kim J; Almazan F; Witztum JL; Miller YI
Autophagy; 2015; 11(5):785-95. PubMed ID: 25946330
[TBL] [Abstract][Full Text] [Related]
15. In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish.
Fang L; Green SR; Baek JS; Lee SH; Ellett F; Deer E; Lieschke GJ; Witztum JL; Tsimikas S; Miller YI
J Clin Invest; 2011 Dec; 121(12):4861-9. PubMed ID: 22105168
[TBL] [Abstract][Full Text] [Related]
16. Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein.
Chang SH; Johns M; Boyle JJ; McConnell E; Kirkham PA; Bicknell C; Zahoor-ul-Hassan Dogar M; Edwards RJ; Gale-Grant O; Khamis R; Ramkhelawon KV; Haskard DO
Hybridoma (Larchmt); 2012 Apr; 31(2):87-98. PubMed ID: 22509912
[TBL] [Abstract][Full Text] [Related]
17. Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease.
Duryee MJ; Clemens DL; Opperman PJ; Thiele GM; Duryee LM; Garvin RP; Anderson DR
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884754
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
19. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
